Drug screening in a zebrafish model of Duchenne muscular dystrophy. - Wikidata - awgldk - TriplyDB

Drug screening in a zebrafish model of Duchenne muscular dystrophy.

Drug screening in a zebrafish model of Duchenne muscular dystrophy.

http://www.wikidata.org/entity/Q33845739

about

Defects of the Glycinergic Synapse in Zebrafish.Model organisms in the fight against muscular dystrophy: lessons from drosophila and Zebrafish Swimming into prominence: the zebrafish as a valuable tool for studying human myopathies and muscular dystrophies.Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery Dasatinib as a treatment for Duchenne muscular dystrophy A splice site mutation in laminin-α2 results in a severe muscular dystrophy and growth abnormalities in zebrafish Hanging on for the ride: adhesion to the extracellular matrix mediates cellular responses in skeletal muscle morphogenesis and disease Zebrafish chemical screening reveals the impairment of dopaminergic neuronal survival by cardiac glycosides Recent advances using zebrafish animal models for muscle disease drug discovery Characterization of Zebrafish Models of Marinesco-Sjögren Syndrome Applications of chemogenomic library screening in drug discovery Using Touch-evoked Response and Locomotion Assays to Assess Muscle Performance and Function in Zebrafish Bridging integrator 1 (Bin1) deficiency in zebrafish results in centronuclear myopathy.NAD+ biosynthesis ameliorates a zebrafish model of muscular dystrophy.PDE5 inhibition alleviates functional muscle ischemia in boys with Duchenne muscular dystrophy.Fluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy.The developing zebrafish (Danio rerio): a vertebrate model for high-throughput screening of chemical libraries.The proteasomal inhibitor MG132 prevents muscular dystrophy in zebrafish.High throughput screening for compounds that alter muscle cell glycosylation identifies new role for N-glycans in regulating sarcolemmal protein abundance and laminin binding Dystrophin is a tumor suppressor in human cancers with myogenic programs.Zebrafish based small molecule screens for novel DMD drugs.High throughput screening in duchenne muscular dystrophy: from drug discovery to functional genomics Regio- and stereoselective synthesis of spirooxindole 1'-nitro pyrrolizidines with five concurrent stereocenters under aqueous medium and their bioprospection using the zebrafish (Danio rerio) embryo model.Dystrophic muscle improvement in zebrafish via increased heme oxygenase signaling.A manual small molecule screen approaching high-throughput using zebrafish embryos.Identification of aggregation inhibitors of the human antibody light chain repertoire by phage display.ColVI myopathies: where do we stand, where do we go?Challenges in understanding psychiatric disorders and developing therapeutics: a role for zebrafish.Small zebrafish in a big chemical pond.Porcine models of muscular dystrophy Hooked! Modeling human disease in zebrafish.Zebrafish models flex their muscles to shed light on muscular dystrophies.Analysis of Zebrafish Larvae Skeletal Muscle Integrity with Evans Blue Dye.Galanin regulates blood glucose level in the zebrafish: a morphological and functional study.Vascular-targeted therapies for Duchenne muscular dystrophy MicroRNA-199a is induced in dystrophic muscle and affects WNT signaling, cell proliferation, and myogenic differentiation.Reversal of neurobehavioral social deficits in dystrophic mice using inhibitors of phosphodiesterases PDE5A and PDE9A.Force measurement during contraction to assess muscle function in zebrafish larvae.Transcriptional changes and developmental abnormalities in a zebrafish model of myotonic dystrophy type 1.Membrane-myofibril cross-talk in myofibrillogenesis and in muscular dystrophy pathogenesis: lessons from the zebrafish.

P2860

Q26738425-CCF0DA5A-1B38-4402-8E2F-E797EA39F607 Q26991681-DDFA82E1-890E-4FC9-8D05-CE56DE31D4C7 Q27028125-3A5C84EE-6C5D-48D2-99F0-6D526CC53AAE Q27144251-FB818FB4-372F-4D92-B998-D3FB2845F0E8 Q27300846-23C6546D-421B-4BF7-9F88-E4CC650AE355 Q27322025-FB60FDBD-1C1D-4BC3-8EB4-338A6847354A Q28087402-0BC792A7-66ED-4FBF-B3ED-7A46BD1A9910 Q28482588-1AF3A720-F775-4FEF-A593-3959D726A7AB Q28551915-64695B03-54D9-4EA8-9D47-22B1B85BBC6A Q28553053-40450E37-0104-454C-BCB0-24651A74FAB3 Q28656335-32725B13-7FF4-4CD3-BA5F-4A4778E3925C Q28817560-CBF5E136-3237-43CF-A4B6-A9DAB8C7C37D Q30580169-DB68C5CC-F8BF-4812-BD0C-45ED065724BA Q31105806-38BBC32C-6BBA-4970-B28C-0E488EA9BA89 Q33987140-626646F0-37AB-4F12-A5D8-43966A4813AB Q33991780-609AB8EA-3093-4E71-81FF-8D4892975137 Q34024345-39AF57E8-0BF5-482A-9D43-FCD49ECF81AF Q34087155-1D49A92F-2A95-4263-9A13-B389AE817FBF Q34262912-7728411F-9EE8-4FCC-BF26-8911F28ADB97 Q34479070-EE0CC821-4D13-4B0E-8E31-300440556438 Q34706642-8E2810BC-4451-4A21-822F-0525F0C69172 Q34792390-4EF0E59B-E612-4F44-BE3B-A4C19D329220 Q34996666-41973C31-D1D0-4B22-9751-CFC34D954FB4 Q35043351-9431E2EB-0A55-422B-92A5-D05A4C39D690 Q35158510-E30D1338-0BE4-454A-8D70-1F9B68745582 Q35211434-73746A0F-F7C5-49D2-96C4-5ECA5AB99229 Q35290709-9EFC52F1-F567-4F87-9F7B-82B93EEFE4CD Q35802879-C5851DDF-22FD-4ABC-96E2-97B078FA0A69 Q35951647-A5F1D352-7837-4614-B96A-BCEE02A57B00 Q35974809-697A2614-8F28-455C-B6DB-7E90E09D9CDA Q36068284-35DFEC8B-1DE6-4C56-BD7B-87290C899DAD Q36359190-9785CCE2-0AF8-49FF-85BC-7EB73D66F865 Q36408382-C938E3EA-760F-4BC0-BEB9-E6FCE49E4A8A Q36456375-49C18D4A-B679-460A-B805-0F813FF09D2A Q36835180-9E25E932-0AA1-4144-8CE7-5819D4602C2B Q37090136-EEB5E44A-940D-4B82-B77F-D2A2E5214E66 Q37307216-A565FCFC-580B-476E-8A08-B44D42067505 Q37354921-694BDE78-8E8A-4F19-AB3C-BD9C1AFE6AB5 Q37438540-351DBF87-4EC6-4EBB-A7AC-BED16273662B Q37522475-6B50779A-622D-49E6-9367-FD59222BCE40

P2860

Drug screening in a zebrafish model of Duchenne muscular dystrophy.

http://www.wikidata.org/entity/Q33845739

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Drug screening in a zebrafish model of Duchenne muscular dystrophy.

@ast

Drug screening in a zebrafish model of Duchenne muscular dystrophy.

@en

type

label

Drug screening in a zebrafish model of Duchenne muscular dystrophy.

@ast

Drug screening in a zebrafish model of Duchenne muscular dystrophy.

@en

prefLabel

Drug screening in a zebrafish model of Duchenne muscular dystrophy.

@ast

Drug screening in a zebrafish model of Duchenne muscular dystrophy.

@en

P1433

Q33845739-51019EF8-6B9D-45FF-A772-E52F31B6FDF0

P1476

Q33845739-58D769F0-CD83-4D2E-876D-98A01BFF2FA6

P2093

Q33845739-1FFD4462-5FD0-4F85-B7AD-3FEFDC1AD388

Q33845739-9603EE17-E7CE-4578-B06D-5CE335953A2C

Q33845739-CC44D100-9DC5-4497-A019-6E944EE00561

Q33845739-D3584D01-4D27-4D22-8A62-9E7EC2F88EB2

P2860

Q33845739-024A1279-E2AE-4DC1-806F-D5EEA59883C8

Q33845739-04458D50-FA1C-4F87-A1E7-D95903E0ACD5

Q33845739-0A73299B-472A-48AD-A7AC-5C2AFEB5B791

Q33845739-0DA63869-9D0F-4D5B-BBCF-21C150B7C402

Q33845739-102BEE61-0BB6-4F58-B870-4935A747E8BE

Q33845739-1C8DBA50-BF7A-4DA3-ABA0-965846F99947

Q33845739-31D258AB-F4D5-4384-9778-0FAE368EEB27

Q33845739-54F3269B-1CB1-495B-84C4-5EF06E62949D

Q33845739-6038194B-EFCD-48D8-95C1-CE709AEB14BF

Q33845739-6A3663ED-3A1B-430E-9AB2-27E24D8F5845

P304

Q33845739-BC31A2AC-6D31-4C59-891C-E71830C0826D

P31

Q33845739-44C5E875-5A5F-4E1F-85DB-395DCC2B176A

P356

Q33845739-BFBD0B7B-7DE1-4B18-BA0D-E2E5FE2ED67F

P407

Q33845739-B37D90C0-6139-4935-B3A0-AA84382BCC39

P433

Q33845739-3EE30572-CE95-43B7-8141-F325A386FFDC

P478

Q33845739-57E44D5A-BAEC-48D6-A235-913CB100D6D7

P50

Q33845739-A90F3870-EFDC-4151-BA08-EBF06E82808F

Q33845739-CE1E503F-87F0-4FE1-BB04-16F80D5C3202

P577

Q33845739-A9472117-5072-49EA-9558-BF021C07B4EE

P5875

Q33845739-580B00C8-DA6C-4EC5-A749-2224ABDDC6B0

P698

Q33845739-76BE695E-7EF2-435A-878E-FD4569B24DC2

P921

Q33845739-4591A25B-FA2F-4AE9-8396-1252D361291E

Q33845739-81000FF5-EC00-43A0-8B55-B01EC90EDAD8

P932

Q33845739-B42B81A6-B22A-4BCD-98AA-7A229CECB17C

P356

PNAS.1102116108

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Drug screening in a zebrafish model of Duchenne muscular dystrophy

@en

P2093

Genri Kawahara

http://www.w3.org/2001/XMLSchema#string

Jeffrey R Guyon

http://www.w3.org/2001/XMLSchema#string

Jeremy A Karpf

http://www.w3.org/2001/XMLSchema#string

Louis M Kunkel

http://www.w3.org/2001/XMLSchema#string

P2860

An anchored PKA and PDE4 complex regulates subplasmalemmal cAMP dynamics

Primary role of functional ischemia, quantitative evidence for the two-hit mechanism, and phosphodiesterase-5 inhibitor therapy in mouse muscular dystrophy

Stages of embryonic development of the zebrafish

The dystrophin associated protein complex in zebrafish.

Small molecules that delay S phase suppress a zebrafish bmyb mutant.

Zebrafish orthologs of human muscular dystrophy genes

Zebrafish models for human FKRP muscular dystrophies

Zebrafish: a model system for the study of human disease.

Convergent regulation of skeletal muscle Ca2+ channels by dystrophin, the actin cytoskeleton, and cAMP-dependent protein kinase.

PTC124 targets genetic disorders caused by nonsense mutations.

P304

5331-5336

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1102116108

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Matthew Alexander

Jennifer A Myers

P577

2011-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50395121

http://www.w3.org/2001/XMLSchema#string

P698

21402949

http://www.w3.org/2001/XMLSchema#string

P921

P932

3069215

http://www.w3.org/2001/XMLSchema#string